To explore the clinical efficacy of 3D printing fracture models to assist in creating pre-contoured plates to treat proximal third humeral shaft fractures. We retrospectively identified proximal third humeral shaft fractures treated between February 2012 and February 2015. The patients were divided into two groups according to the treatment procedure: a Synbone group and a 3D-printed group. In the Synbone group, long proximal humeral internal locking system plates were pre-contoured into helical shape on Synbones before surgery, while in the 3D-printed group, they were contoured on 3D-printed bone models. The pre-contoured plates were sterilized before surgery and were then used for fracture fixation during surgery. Duration of surgeries, blood loss volumes, the incidence of complications, and the time to fracture union were recorded, and functional outcomes were assessed by the Constant-Murley shoulder score and the Mayo Elbow Performance Score (MEPS) at 1-year follow-up. The subjects comprised 46 patients; 25 patients were allocated to the Synbone group and the remaining 21 to the 3D-printed group. There was no significant difference between the baseline characteristics of the two groups. At the 1-year follow-up visit, all fractures were healed and showed a satisfactory outcome. There were no instances of iatrogenic radial nerve injury, and there was no significant difference between the two groups with regard to fracture union time, Constant-Murley score, or MEPS score. Surgery duration was significantly shorter in the 3D-printed group compared to the Synbone group (42.62 vs. 60.36 min, P = 0.001), and the 3D-printed group lost less blood during surgery (105.19 vs. 120.80 ml, P = 0.001). In addition, in the 3D-printed group, 9 surgeries were finished by senior attending doctors and 12 were finished by junior attending doctors; however, there was no significant difference between the 1-year outcomes of the two grades of surgeons. Our results show that the 3D printing technique is helpful in shortening the duration of surgery, reducing blood loss volume, and in making this surgical procedure easier for less-experienced surgeons. This clinical study was registered in CHICTR on September 30, 2017 (number 17012852 ).
Introduction: The infrapatellar fat pad and synovium are the sites of immune cell infiltration and the origin of proinflammation. Studies have shown that Hoffa’s synovitis may be a sign of early-stage osteoarthritis (OA). However, there have been no effective interventions specifically for Hoffa’s synovitis.Methods and analysis: We will conduct a multicentre, multi-blind (participant, physician, outcome assessor and data analyst blinded) randomised controlled trial to compare the effectiveness of an intra-infrapatellar fat glucocorticoid versus an intra-articular injection for Hoffa’s synovitis in patients with knee OA. We will recruit 236 knee OA patients with Hoffa’s synovitis at outpatient clinics in three centres. We will randomly allocate them to two groups in a 1:1 ratio. One group will receive ultrasound-guided injection of 40 mg (1 mL) triamcinolone acetonide into the infrapatellar fat pad; the other group will receive ultrasound-guided injection of 40 mg (1 mL) triamcinolone acetonide into the knee joint cavity. All patients will be followed up at 2, 4, 8, 12 and 24 weeks after the injection. Primary outcomes are (1) Hoffa’s synovitis improvement rate, measured with the MRI Osteoarthritis Knee Score system (superiority outcome) at 24 weeks and (2) pain intensity, measured with the Western Ontario and McMasters University Osteoarthritis Index (WOMAC) at 2 weeks post-injection. Secondary outcomes include Hoffa’s synovitis score at 2 weeks post-injection, pain intensity with the numerical rating scale, WOMAC questionnaire score improvements (function, joint stiffness and total score), improvement rates in effusion synovitis at 2 and 24 weeks, articular cartilage thickness changes at 2 and 24 weeks, Intermittent and Constant Osteoarthritis Pain score, quality of life measured with the EuroQol-5D, OARSI-OMERACT response indicators, co-interventions and side effects at 2, 4, 8, 12 and 24 weeks.Ethics and dissemination: Ethical approval has been granted by the Medical Ethics Committee of the Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (2023–178). Written informed consent will be obtained from all patients prior to data collection. The findings of this research will be shared through presentations at academic conferences and publications in peer-reviewed journals.Trial registration number: ChiCTR2400080474.
Background: To identify the optimal viewing angles for every proximal screw in PHILOS plate-fixed proximal humeral fractures. Methods: Three fresh-frozen human cadaveric bodies with six intact shoulders were studied. All three bodies were put in the beach chair position and PHILOS plates were placed on the proximal humerus. Head screws penetrating 1 mm into the joint were fitted one by one. Fluoroscopy was conducted in the 180 degrees horizontal plane and the 120 degrees coronal plane to analyze each screw's penetration in every shoulder. Images were taken every 5 degrees, then all images were analyzed to identify the sensitive angles. Results: The range of optimal viewing angles to visualize penetration of every head screw was identified. In the coronal plane, the angles in the range between 0 degrees and 10 degrees were sensitive to all screws except No. 8 and No. 9. Furthermore, penetration of screws No. 8 and 9 could not be identified on any axillary view, but could be identified in the horizontal plane from -30 degrees to -10 degrees and from 10 degrees to 35 degrees respectively. Conclusions: We recommend a 0 degrees-10 degrees axillary view with 30 degrees arm abduction combined with two horizontal angles in the range of -30 degrees to -10 degrees and 10 degrees to 35 degrees for routine fluoroscopy during surgery. Our results will be helpful in avoiding primary screw penetration.
4 June 2025 in Journal of Orthopaedic Surgery and Research
Proximal humeral fractures are common injuries in the elderly population, with their incidence expected to rise due to increased life expectancy. A small subset of these fractures may be associated with dislocating forces that can result in shoulder dislocation concurrent with the fracture. For the elderly patients, proximal humeral fracture dislocation can be treated by open reduction and internal locking plate (LP) fixation or reverse shoulder arthroplasty (RSA). By now, no high-quality trials have compared the two. This study is a prospective, single-center, superiority randomized controlled trial (RCT) comparing RSA and LP fixation in elderly patients (aged 65 to 85 years) with a proximal humeral fracture dislocation. Eligible participants will be randomly assigned to either the RSA or LP group (1:1 ratio). Postoperative follow-up will be conducted at 1 day (in the ward), 1 month, 3 months, 6 months, 12 months, and 24 months after surgery. Primary outcome is the Constant-Murley Score at 1-year postoperatively. Secondary outcomes include short version of Disabilities of the Arm Shoulder and Hand questionnaire score, American Shoulder and Elbow Surgeons score, Visual Analog Scale score, EuroQol-5 Dimension score, range of motion, strength and postoperative complications. This trial is the first RCT comparing RSA with LP fixation for proximal humeral fracture dislocations in elderly patients. The results of this study will provide high-quality evidence to guide clinical practice. China Clinical Trials Registry No. ChiCTR2400088249.
25 June 2026 in Journal of Orthopaedics and Traumatology
Fibular allograft (FA) augmentation is proposed to address the lack of medial column support in plate-fixed proximal humeral fractures; however, the role o